Givaudan Résultats passés
Passé contrôle des critères 3/6
Givaudan a connu une croissance annuelle moyenne de ses bénéfices de 8.3%, tandis que le secteur Chemicals a vu ses bénéfices augmenter de en hausse à 0.4% par an. Les revenus ont augmenté de en hausse à un taux moyen de 3.2% par an. Le rendement des capitaux propres de Givaudan est 23.4% et ses marges nettes sont de 14.3%.
Informations clés
8.34%
Taux de croissance des bénéfices
8.32%
Taux de croissance du BPA
| Chemicals Croissance de l'industrie | 5.98% |
| Taux de croissance des recettes | 3.18% |
| Rendement des fonds propres | 23.45% |
| Marge nette | 14.33% |
| Prochaine mise à jour des résultats | 23 Jul 2026 |
Mises à jour récentes des performances passées
Recent updates
Mise à jour du récit • Jun 09
GIVN: Pricing Power And Eurofragance Deal Will Support Future Margin Resilience
The analyst price target for Givaudan has been adjusted slightly to CHF 3,415 from CHF 3,447. This reflects a blend of cautious tweaks to growth and discount rate assumptions.
Mise à jour du récit • May 26
GIVN: AI Beauty Partnership Will Support Future Re Rating Potential
Analysts have trimmed their Givaudan fair value estimate from CHF 5,040 to about CHF 4,284, reflecting expectations of lower revenue growth, slightly softer profit margins, a modestly reduced discount rate, and a lower future P/E multiple following a series of recent target cuts and rating changes. Analyst Commentary Recent Street research on Givaudan has been mixed, with several cuts to price targets and rating changes, but not all commentary has been negative.
Mise à jour du récit • May 02
GIVN: Fair Outlook Will Reflect Split Bank Views And AI Beauty Push
Givaudan's analyst price target has been reset from CHF 2,875 to CHF 2,800, as analysts weigh recent upgrades alongside a mix of smaller target increases and larger reductions from major banks. Analyst Commentary Recent Street research around Givaudan has been mixed, with some upgrades and modest price target increases sitting alongside a series of larger cuts and downgrades from major banks.Mise à jour du récit • Apr 18
GIVN: Fair Outlook Balances Dividend Stability With Mixed Bank Rating Revisions
Givaudan's analyst price target is held at CHF 2,875, with minor adjustments to the discount rate, revenue growth, and profit margin assumptions reflecting a mixed set of recent analyst actions, including modest price target changes and rating shifts across major banks. Analyst Commentary Recent research on Givaudan shows a split view, with some large banks turning more constructive while several bearish analysts continue to flag risks around valuation and execution.Mise à jour du récit • Apr 04
GIVN: Cautious Downgrades Will Support Future Margin Resilience And Re Rating Potential
Givaudan's analyst price target has been reduced from about CHF 3,748 to roughly CHF 3,447. This reflects analysts' recent rounds of target cuts and downgrades following more cautious assumptions on growth, margins and future P/E multiples.Mise à jour du récit • Mar 21
GIVN: Fair Stance Will Balance Dividend Appeal And Cautious Bank Revisions
Givaudan's analyst price target is trimmed to CHF 2,875 from CHF 2,900 as analysts factor in more cautious assumptions about revenue growth, slightly firmer profit margins and updated P/E expectations following a series of recent target cuts across the Street. Analyst Commentary Recent Street research around Givaudan has leaned more cautious, with several bearish analysts trimming price targets and reassessing the risk and reward trade off.Mise à jour du récit • Mar 06
GIVN: Fair Stance Will Weigh Dividend Support Against Cautious Bank Views
Analysts have trimmed their Givaudan price targets by up to several hundred CHF, reflecting slightly lower assumptions for revenue growth and profit margins while keeping fair value broadly anchored around CHF 2,900 as they adjust discount rate and P/E inputs. Analyst Commentary Recent Street research on Givaudan skews cautious, with several bearish analysts cutting price targets by CHF 150 to CHF 400 as they reset their expectations around revenue growth, margins, and the appropriate P/E to pay for the shares.Mise à jour du récit • Feb 20
GIVN: Fair Stance Will Reflect Cautious Bank Views On Future Earnings
Analysts have lowered their price target on Givaudan to CHF 2,900 from CHF 3,100, reflecting updated assumptions around slightly higher discount rates, more cautious revenue growth, a marginally lower profit margin outlook, and a modestly reduced future P/E multiple in light of recent target cuts and a downgrade from several major banks. Analyst Commentary Recent Street research on Givaudan has tilted more cautious, with a cluster of price target cuts and at least one fresh downgrade from a major global bank.Mise à jour du récit • Feb 06
GIVN: Chinese Pricing Pressure Will Support Future Margin Resilience And Re Rating Potential
Analysts have reduced their fair value estimate for Givaudan from CHF 3,946.93 to CHF 3,747.83. This change reflects a series of lower Street price targets and incorporates assumptions for steady revenue growth, slightly higher profit margins and a lower future P/E multiple.Article d’analyse • Feb 01
Givaudan (VTX:GIVN) Is Increasing Its Dividend To CHF72.00
The board of Givaudan SA ( VTX:GIVN ) has announced that it will be paying its dividend of CHF72.00 on the 25th of...Mise à jour du récit • Jan 23
GIVN: Recalibrated Valuation Support Will Sustain Outperformance Versus Chinese Pricing Pressure
Our updated analyst price target for Givaudan shifts to CHF 3,947 from CHF 4,021, as analysts factor in only modest adjustments to growth, margins, and future P/E assumptions, while recent upgrades highlight improved relative positioning and valuation support. Analyst Commentary Recent research suggests sentiment around Givaudan is improving, with upgrades linked mainly to valuation support and relative positioning versus peers, rather than big changes to fundamental assumptions.Mise à jour du récit • Jan 09
GIVN: Fair Stance Will Reflect Resilience To Chinese Pricing Pressure
Analysts now frame their Givaudan price target at CHF 3,100, with updated assumptions reflecting a 3.9% revenue growth outlook, a 15.4% profit margin profile, and a forward P/E of about 24.5x. This view is supported by recent upgrades that highlight valuation and relative resilience versus Chinese competition and pricing pressure.Mise à jour du récit • Dec 18
GIVN Will Face Mixed Rating Shifts Amid Intensifying Competition And Pricing Pressures
Analysts have trimmed their price target for Givaudan by CHF 100 to CHF 3,100. This reflects slightly softer assumptions for long term revenue growth and margins, even as they continue to view the company as relatively well positioned against intensifying competition and pricing pressures.Mise à jour du récit • Dec 04
GIVN: Peer-Leading Organic Sales Will Sustain Outperformance Versus Chinese Competition
Analysts have nudged their fair value estimate for Givaudan slightly higher, from approximately CHF 3,995 to CHF 4,021. This reflects modest upgrades to long term revenue growth and profit margin assumptions as they emphasize the company’s relative resilience to Chinese competition and its peer leading organic sales growth.Article d’analyse • Nov 28
Subdued Growth No Barrier To Givaudan SA's (VTX:GIVN) Price
When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 19x, you may consider...Mise à jour du récit • Nov 20
GIVN: Peer-Leading Organic Sales Growth Will Drive Outperformance Amid Competitive Pressures
Analysts have slightly reduced their fair value estimate for Givaudan, lowering the price target from approximately CHF 4,005 to CHF 3,995. This adjustment reflects recent cautious sentiment amid ongoing pricing and competitive pressures in the sector.Article d’analyse • Nov 12
Returns At Givaudan (VTX:GIVN) Are On The Way Up
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...Mise à jour du récit • Nov 05
GIVN: Peer-Leading Organic Sales Growth Will Support Share Price Recovery
Analysts have decreased their price targets for Givaudan, citing persistent challenges in the consumer chemicals sector and a cautious outlook on peer-relative performance. The targets now range from CHF 3,300 to CHF 3,725, down from previous estimates by several hundred francs.Article d’analyse • Oct 28
Estimating The Intrinsic Value Of Givaudan SA (VTX:GIVN)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Givaudan fair value estimate is CHF4,284 With CHF3,471 share...Mise à jour du récit • Oct 22
Analysts Weigh Givaudan’s Outlook Amid CEO Transition and Adjusted Growth Forecasts
Analysts have slightly raised Givaudan's fair value estimate from CHF 3,996.53 to CHF 4,005.42. This change reflects updated expectations in light of moderated growth forecasts and cautious sentiment highlighted in recent price target revisions.Mise à jour du récit • Oct 08
Emerging Markets And Sustainable Ingredients Will Drive Future Expansion
Givaudan's analyst price target has been revised downward from CHF 4,081.95 to CHF 3,996.53, reflecting slightly lower revenue growth expectations and profit margin forecasts according to recent analyst updates. Analyst Commentary Recent analyst activity on Givaudan has resulted in a mix of revised targets and sentiment shifts that reflect both optimism around the company's strengths and caution regarding its outlook in the current market environment.Mise à jour du récit • Sep 23
Emerging Markets And Sustainable Ingredients Will Drive Future Expansion
Despite near-term pressures and a sector-wide derating, analysts remain positive on Givaudan's strong organic sales growth and long-term structural opportunities—particularly from regulatory-driven reformulation trends—resulting in only a marginal reduction of the consensus price target from CHF4127 to CHF4082. Analyst Commentary Givaudan is recognized for peer-leading organic sales growth, positioning it as a best-in-class flavor and fragrance company.Article d’analyse • Sep 22
Here's Why We Think Givaudan (VTX:GIVN) Is Well Worth Watching
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Mise à jour du récit • Sep 04
Emerging Markets And Sustainable Ingredients Will Drive Future Expansion
Analysts remain moderately optimistic on Givaudan, citing long-term benefits from regulatory-driven reformulation and market share gains tempered by near-term margin pressures and valuation concerns, resulting in an unchanged consensus price target of CHF4127. Analyst Commentary Bullish analysts expect Givaudan to benefit from industry-wide reformulation trends starting in 2026 as regulatory pressures phase out synthetic colors and ingredients, particularly in the U.S. Increases in price targets reflect confidence in Givaudan’s ability to capture incremental market share and drive organic growth amid evolving consumer preferences.Article d’analyse • Aug 22
Does Givaudan (VTX:GIVN) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Article d’analyse • Jul 24
Givaudan SA (VTX:GIVN) Half-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Last week, you might have seen that Givaudan SA ( VTX:GIVN ) released its interim result to the market. The early...Article d’analyse • Jul 17
Givaudan SA's (VTX:GIVN) Price Is Out Of Tune With Earnings
With a price-to-earnings (or "P/E") ratio of 31.8x Givaudan SA ( VTX:GIVN ) may be sending very bearish signals at the...
Nouveau récit • Jan 26
Bloomful Splash Launch Will Drive Future Success In Fragrance & Beauty
Strategic leadership changes and portfolio expansions may drive growth in revenue and earnings.Ventilation des recettes et des dépenses
Ventilation des recettes et des dépenses
Comment Givaudan gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Dec 25 | 7,472 | 1,071 | 1,236 | 551 |
| 30 Sep 25 | 7,506 | 1,083 | 1,251 | 556 |
| 30 Jun 25 | 7,539 | 1,094 | 1,266 | 560 |
| 31 Mar 25 | 7,476 | 1,092 | 1,244 | 563 |
| 31 Dec 24 | 7,412 | 1,090 | 1,222 | 565 |
| 30 Sep 24 | 7,265 | 1,061 | 1,184 | 551 |
| 30 Jun 24 | 7,117 | 1,032 | 1,146 | 537 |
| 31 Mar 24 | 7,016 | 963 | 1,126 | 528 |
| 31 Dec 23 | 6,915 | 893 | 1,105 | 519 |
| 30 Sep 23 | 6,958 | 879 | 1,106 | 518 |
| 30 Jun 23 | 7,000 | 865 | 1,106 | 516 |
| 31 Mar 23 | 7,059 | 861 | 1,109 | 519 |
| 31 Dec 22 | 7,117 | 856 | 1,112 | 522 |
| 30 Sep 22 | 7,040 | 818 | 1,130 | 538 |
| 30 Jun 22 | 6,963 | 780 | 1,148 | 553 |
| 31 Mar 22 | 6,824 | 801 | 1,157 | 558 |
| 31 Dec 21 | 6,684 | 821 | 1,165 | 562 |
| 30 Sep 21 | 6,579 | 816 | 1,145 | 557 |
| 30 Jun 21 | 6,474 | 811 | 1,124 | 552 |
| 31 Mar 21 | 6,398 | 777 | 1,098 | 544 |
| 31 Dec 20 | 6,322 | 743 | 1,072 | 536 |
| 30 Sep 20 | 6,326 | 739 | 1,063 | 533 |
| 30 Jun 20 | 6,330 | 735 | 1,054 | 530 |
| 31 Mar 20 | 6,267 | 719 | 1,038 | 529 |
| 31 Dec 19 | 6,203 | 702 | 1,021 | 528 |
| 30 Sep 19 | 6,075 | 687 | 1,000 | 520 |
| 30 Jun 19 | 5,947 | 672 | 978 | 512 |
| 31 Mar 19 | 5,737 | 668 | 956 | 495 |
| 31 Dec 18 | 5,527 | 663 | 934 | 477 |
| 30 Sep 18 | 5,385 | 685 | 914 | 460 |
| 30 Jun 18 | 5,242 | 707 | 894 | 442 |
| 31 Mar 18 | 5,147 | 714 | 877 | 433 |
| 31 Dec 17 | 5,051 | 720 | 859 | 424 |
| 30 Sep 17 | 4,932 | 690 | 849 | 417 |
| 30 Jun 17 | 4,812 | 660 | 839 | 409 |
| 31 Mar 17 | 4,738 | 652 | 839 | 405 |
| 31 Dec 16 | 4,663 | 644 | 839 | 400 |
| 30 Sep 16 | 4,605 | 648 | 829 | 390 |
| 30 Jun 16 | 4,546 | 651 | 819 | 380 |
| 31 Mar 16 | 4,471 | 638 | 806 | 373 |
| 31 Dec 15 | 4,396 | 625 | 793 | 366 |
| 30 Sep 15 | 4,397 | 613 | 800 | 378 |
| 30 Jun 15 | 4,397 | 600 | 807 | 390 |
Des revenus de qualité: GIVN a des bénéfices de haute qualité.
Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de GIVN sont inférieures à celles de l'année dernière GIVN. (14.3%) sont inférieures à celles de l'année dernière (14.7%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: Les bénéfices de GIVN ont augmenté de 8.3% par an au cours des 5 dernières années.
Accélération de la croissance: GIVN a connu une croissance négative de ses bénéfices au cours de l'année écoulée, elle ne peut donc pas être comparée à sa moyenne sur 5 ans.
Bénéfices par rapport au secteur d'activité: GIVN a enregistré une croissance négative de ses bénéfices ( -1.7% ) au cours de l'année écoulée, ce qui rend difficile la comparaison avec la moyenne du secteur Chemicals ( 2.8% ).
Rendement des fonds propres
ROE élevé: Le retour sur capitaux propres de GIVN ( 23.4% ) est considéré comme élevé.
Rendement des actifs
Rendement des capitaux employés
Découvrir des entreprises performantes dans le passé
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/06/19 21:51 |
| Cours de l'action en fin de journée | 2026/06/19 00:00 |
| Les revenus | 2025/12/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d'analyse utilisé pour générer ce rapport sont disponibles sur notre page Github, nous proposons également des guides pour apprendre à utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Givaudan SA est couverte par 36 analystes. 18 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Konstantin Wiechert | Baader Helvea Equity Research |
| Volker Bosse | Baader Helvea Equity Research |
| James Knight | Barclays |